Co-Authors
This is a "connection" page, showing publications co-authored by Yunbao Pan and Yirong Li.
Connection Strength
6.385
-
Correction: SARS-CoV-2-specific immune response in COVID-19 convalescent individuals. Signal Transduct Target Ther. 2021 Jul 30; 6(1):293.
Score: 0.959
-
SARS-CoV-2-specific immune response in COVID-19 convalescent individuals. Signal Transduct Target Ther. 2021 07 07; 6(1):256.
Score: 0.955
-
Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients. J Infect. 2020 07; 81(1):e28-e32.
Score: 0.876
-
Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Signature in Head and Neck Squamous Cell Carcinoma. Front Pharmacol. 2019; 10:150.
Score: 0.812
-
Analysis of differential gene expression profile identifies novel biomarkers for breast cancer. Oncotarget. 2017 Dec 29; 8(70):114613-114625.
Score: 0.745
-
DNA methylation profiles in cancer diagnosis and therapeutics. Clin Exp Med. 2018 Feb; 18(1):1-14.
Score: 0.726
-
High Performance of SARS-Cov-2N Protein Antigen Chemiluminescence Immunoassay as Frontline Testing for Acute Phase COVID-19 Diagnosis: A Retrospective Cohort Study. Front Med (Lausanne). 2021; 8:676560.
Score: 0.239
-
Aberrant cytokine expression in COVID-19 patients: Associations between cytokines and disease severity. Cytokine. 2021 07; 143:155523.
Score: 0.234
-
The Utility of Specific Antibodies Against SARS-CoV-2 in Laboratory Diagnosis. Front Microbiol. 2020; 11:603058.
Score: 0.231
-
Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign. Clin Microbiol Infect. 2021 Feb; 27(2):253-257.
Score: 0.227
-
Can routine laboratory tests discriminate SARS-CoV-2-infected pneumonia from other causes of community-acquired pneumonia? Clin Transl Med. 2020 Jan; 10(1):161-168.
Score: 0.215
-
Tracing asymptomatic SARS-CoV-2 carriers among 3674 hospital staff:a cross-sectional survey. EClinicalMedicine. 2020 Sep; 26:100510.
Score: 0.056
-
Re: Profile of specific antibodies to SARS-CoV-2: The first report. J Infect. 2020 07; 81(1):e80-e81.
Score: 0.055
-
Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation. J Infect. 2020 05; 80(5):e14-e17.
Score: 0.055